Core Insights - Intelligent Bio Solutions Inc. achieved record monthly cartridge sales in July 2025, with 519 boxes shipped, translating to over 12,500 cartridges and a 60% year-on-year growth [1][2]. Group 1: Business Model and Revenue Growth - Cartridges are a high-margin consumable in the Company's fingerprint sweat-based drug testing system, forming the basis of its razor/razor blade business model, which is experiencing growth due to new large contracts and an expanding global installed base [2][3]. - The Company secured a significant multi-site, high-volume contract in the transportation sector, which has increased ongoing demand for consumables [2]. - There is a growing pipeline of opportunities, with an increasing number of bids and tenders for large-scale deployments, indicating a robust demand for the Company's products [2]. Group 2: Management Insights - The President and CEO of Intelligent Bio Solutions highlighted that the record cartridge sales reflect the strength of the business model and the momentum from major contract wins, suggesting continued growth in cartridge demand and reliable revenue streams [3]. - The Company aims to leverage its installed base to drive recurring sales of cartridges while planning for U.S. market expansion beyond forensic use in the second half of 2025 [3]. Group 3: Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on intelligent, rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat [4]. - The technology is designed to be hygienic and cost-effective, screening for drugs commonly found in the workplace, with quick sample collection and results [4]. - Current customer segments outside the U.S. include construction, manufacturing, transport, mining, and drug treatment organizations, indicating a diverse market presence [4].